Rare diseases
Investigational molecules
Locations
Back to Italy219 clinical trials in Parma, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
ItalyStudy of radiotherapy with durvalumab and ceralasertib in patients with stage III non-small cell lung cancer who have thoracic relapse after PACIFIC treatment
ItalyStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
ItalyItalyStudy on Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Transplant
ItalyStudy on the Effectiveness of Doxycycline for Treating Newly Diagnosed Ocular Adnexal Marginal Zone Lymphoma Patients
ItalyStudy on the Effectiveness of Osimertinib for Patients with EGFR Mutant Non-Small Cell Lung Cancer Based on TP53 Mutation Status
ItalyStudy Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients
ItalyStudy on the Effectiveness of Diclofenac Sodium and Thiocolchicoside in Relieving Acute Low Back Pain in Adults
ItalyStudy on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
ItalyStudy on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, lung cancer, and breast cancer treatments. Investigations include innovative immunotherapy approaches and targeted therapies for various cancer types.
Research emphasizes personalized treatment approaches and combination therapies to improve patient outcomes.
Studies examining treatments for respiratory syncytial virus (RSV) infections in high-risk populations. Advanced research into preventive therapies and management strategies.
Focus on developing protective measures for vulnerable patient populations.
Clinical trials evaluating new approaches to kidney transplantation and prevention of complications. Research on reducing delayed graft function and improving transplant outcomes.
Emphasis on enhancing long-term transplant success rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
